XML 57 R4.htm IDEA: XBRL DOCUMENT v2.4.0.6
CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS (USD $)
 3 Months Ended 6 Months Ended 12 Months Ended 129 Months Ended
Jun. 30, 2012
Jun. 30, 2011
Jun. 30, 2012
Jun. 30, 2011
Dec. 31, 2011
Dec. 31, 2010
Dec. 31, 2009
Jun. 30, 2012
CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS [Abstract]                
Research and development expenses, net (Note 11) $ 508,462 $ 407,631 $ 953,528 $ 781,114 $ 1,789,301 $ 934,056 $ 1,005,108 $ 9,509,242
General and administrative expenses (Note 12) 245,613 89,098 448,548 254,736 544,145 457,495 165,156 2,610,282
Other income                (912)    (912)
Operating loss 754,075 496,729 1,402,076 1,035,850 2,333,446 1,390,639 1,170,264 12,118,612
Financing (income) expenses, net (Note 13) (16,617) 19,928 (29,665) 21,071 30,893 1,397,807 32,032 1,771,318
Loss for the period 737,458 516,657 1,372,411 1,056,921 2,364,339 2,788,446 1,202,296 13,889,930
Other comprehensive (income) loss:                
Foreign currency translation adjustment (32,704) (41,239) (21,143) (24) (39,052) 119,019 13,367 (43,777)
Comprehensive loss for the period $ 704,754 $ 475,418 $ 1,351,268 $ 1,056,897 $ 2,325,287 $ 2,907,465 $ 1,215,663  
Loss per share (Basic and Diluted) (Note 15) $ 0.14 $ 0.1 $ 0.26 $ 0.22 $ 0.46 $ 0.7 $ 0.3  
Weighted average number of shares outstanding (Basic and Diluted) (Note 15) 5,295,543 4,989,720 5,295,543 4,922,582 5,091,330 4,034,706 3,995,805